profit from every $100 of sales.
$0$100
The Boston Beer
$221.82+1.00% today
+10.3% in 1 year
1-year low $161.081-year high $260.05
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $20.76 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What The Boston Beer sold, what it kept, and what it did with the cash.
Sales went from $2.09 billion in 2022 to $1.96 billion in 2025, with $108 million of profit last year.
SalesProfit
The Boston Beer handed back 94% of the cash it generated last year.
Buybacks $202M
Free cash flow 2025$216M
Bought back its own shares$202M
Paid as dividends–
Cash vs. debt$223M vs. $38M
The Boston Beer vs. similar companies
The Boston Beer grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| The Boston Beer | 20.8× · Fair price | ||
 Molson Coors Beverage | No profit yet | ||
 Splash Beverage Group | No profit yet | ||
 LQR House | No profit yet | ||
 IP Strategy Holdings | No profit yet |
Compare The Boston Beer with Molson Coors Beverage
AI analysis
An AI analyst reads The Boston Beer's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2,090 | 2,009 | 2,013 | 1,965 | |
| 862 | 852 | 894 | 953 | |
| 126 | 122 | 152 | 152 | |
| 207 | 210 | 246 | 242 | |
| 67 | 76 | 60 | 108 | |
| 5.44 | 6.21 | 5.06 | 9.89 | |
| 41.2% | 42.4% | 44.4% | 48.5% | |
| 6.0% | 6.1% | 7.5% | 7.7% | |
| 3.2% | 3.8% | 3.0% | 5.5% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,421 | 1,430 | 1,250 | 1,194 |
| Cash | 181 | 298 | 212 | 223 |
| Total debt | 54 | 45 | 36 | 38 |
| Total liabilities | 352 | 352 | 334 | 347 |
| 1,069 | 1,078 | 916 | 846 | |
| 12 | 12 | 12 | 11 | |
| 8.9% | 8.6% | 12.6% | 13.6% | |
| 6.3% | 7.1% | 6.5% | 12.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 200 | 265 | 249 | 270 | |
| 91 | 64 | 76 | 55 | |
| 109 | 201 | 173 | 216 | |
| Dividends paid | – | – | – | – |
| 0 | 93 | 239 | 202 | |
| 14 | 17 | 19 | 22 |
Valuation
- 20.8×
- 23.0×
- 0.94
- 2.9×
- 1.1×
- 10.4×
- 8.5×
- 9.6%
- 4.8%
- 0.0%
Profitability
- 48.5%
- 7.7%
- 5.5%
- 12.4%
- 15.5%
- 6.5%
- -7.3%
- -5.2%
- 18.4%
- –
Growth
- −2.0%
- +22.0%
- +24.9%
- –
- −3.6%
Financial health
- -0.5×
- 0.05
- 3.0%
- –
- 0.93
- 0.67
- 1.77
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 22%of 669
Bottom 36%of 672
Bottom 42%of 623
Bottom 12%of 671
Top 22%of 666
What analysts expect
- Average price target
- $246.86
- Range
- $220.00 – $315.00
- 6 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 1.64 | 1.96 | −16.3% |
| Feb 24, 2026 | -2.12 | -2.33 | +9.0% |
| Oct 23, 2025 | 4.25 | 3.78 | +12.4% |
| Jul 24, 2025 | 5.45 | 4.37 | +24.7% |
| Apr 24, 2025 | 2.16 | 0.78 | +176.9% |
| Feb 25, 2025 | -1.68 | -1.21 | −38.8% |
| Oct 24, 2024 | 5.35 | 4.96 | +7.9% |
| Jul 25, 2024 | 4.39 | 5.02 | −12.5% |
News
Can Boston Scientific Stock Bounce Off This Support Again?Yahoo Finance · Oct 22, 2026Sam Stovall says history is key to what happens to the S&P 500 next yearYahoo Finance · Oct 20, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
60Pass
Benjamin Graham
50No pass
Philip Fisher
62Pass
Peter Lynch
65Pass
Joel Greenblatt
42No pass
Charlie Munger
50No pass
Terry Smith
46No pass
Questions about The Boston Beer
Is The Boston Beer a good stock to buy?
A business with weak numbers at a fair price. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the The Boston Beer AI analysis
What does The Boston Beer do?
The Boston Beer Company, Inc. produces and sells alcohol beverages primarily in the United States. The company's flagship beer is Samuel Adams Boston Lager. It is in Beverages - Alcoholic.
Does The Boston Beer pay a dividend?
No. The Boston Beer does not pay a dividend at the moment; in 2025 it returned $202 million to shareholders by buying back its own shares.
Is The Boston Beer stock halal?
No. The Boston Beer does not pass our halal screen: its main business, alcohol, is not permitted. How we check
How has The Boston Beer stock done over the past year?
Up 10.3% over the past twelve months, to $221.82. It traded between $161.08 and $260.05 and is 14.7% below its high.
Who are The Boston Beer's competitors?
The largest listed companies in the same industry are Molson Coors Beverage, Splash Beverage Group, LQR House and IP Strategy Holdings. The peers table on this page compares their profit, growth and price with The Boston Beer's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.